MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'BRIEN, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'BRIEN, R. D.

Molecular Pharmacology, Vol 4, 121-130, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Kinetics of the Carbamylation of Cholinesterase

R. D. O'BRIEN 1

1 Section of Neurobiology and Behavior, Cornell University, Ithaca, New York 14850

The kinetics of inhibition of acetylcholinesterase by three methylcarbamates was explored, and it was shown that the observations of both short-term and steady-state inhibitions were satisfactorily accounted for if one assumed that a reversible complex was formed prior to carbamylation of the enzyme. New kinetic evidence for the existence of such a complex was also provided. Both the complex formation and the carbamylation steps were inhibited by the substrates acetylthiocholine and 1-naphthyl acetate. The decarbamylation step was not affected by 2-pyridine-aldoxime methiodide. 1-Naphthyl methylcarbamate did not affect a muscle preparation containing acetylcholine receptor.

Note:
ACKNOWLEDGMENTS Grateful thanks are due to Miss Lorraine Gilmour, who performed all the experimental work, and Mr. Sam Rhine, who computerized the data. The carbamates were generously donated by Union Carbide Company (carbaryl); Chemagro Corporation (o-isopropoxyphenyl methylcarbamate), and Hooker Chemical Company (3,5-diisopropylphenyl methylcarbamate). We are greatly indebted to the U.S. Public Health Service for Research Grant GM 07804, which supported this work in part.

Submitted on June 26, 1967
Revised on October 26, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics